Cargando…

Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9—A Narrative Review

As dyslipidemias remain one of the main risk factors for developing cardiovascular disease, the question of maintaining optimal lipid levels with pharmacotherapy remains a subject of interest worldwide. In contrast to conventional pharmacotherapy, human monoclonal antibodies directed against proprot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merćep, Iveta, Friščić, Nikolina, Strikić, Dominik, Reiner, Željko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853778/ https://www.ncbi.nlm.nih.gov/pubmed/35237348 http://dx.doi.org/10.1155/2022/8129513

Ejemplares similares

New Therapeutic Approaches in Treatment of Dyslipidaemia—A Narrative Review
por: Merćep, Iveta, et al.
Publicado: (2022)

Small Interfering Ribonucleic Acid as Lipid-Lowering Therapy: Inclisiran in Focus
por: Rakocevic, Jelena, et al.
Publicado: (2023)

Inclisiran—Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9
por: Wołowiec, Łukasz, et al.
Publicado: (2023)

Present and Future of Dyslipidaemia Treatment—A Review
por: Merćep, Iveta, et al.
Publicado: (2023)

PCSK9 inhibitor inclisiran for treating atherosclerosis via regulation of endothelial cell pyroptosis
por: Kong, Ni, et al.
Publicado: (2022)

The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function
por: Di Costanzo, Assunta, et al.
Publicado: (2023)

PCSK9 Inhibitor Wars: How Does Inclisiran Fit in with Current Monoclonal Antibody Inhibitor Therapy? Considerations for Patient Selection
por: Arnold, Natalie, et al.
Publicado: (2022)

Interfering ribonucleic acids that suppress expression of multiple unrelated genes
por: Passioura, Toby, et al.
Publicado: (2009)

Inclisiran: First Approval
por: Lamb, Yvette N.
Publicado: (2021)

Advantages and Disadvantages
Publicado: (1917)

Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran)
por: Sinning, David, et al.
Publicado: (2020)

Correction to: Inclisiran: First Approval
por: Lamb, Yvette N.
Publicado: (2021)

The Advantages and Disadvantages of Specialism
por: Thomas, Reuen
Publicado: (1894)

In vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid delivery
por: Banizs, Anna B, et al.
Publicado: (2014)

Evaluating the Efficacy of a Small Interfering Ribonucleic Acid Molecule, Givosiran, in Treating Acute Intermittent Porphyria: A Systematic Review
por: Patel, Priyansh, et al.
Publicado: (2023)

The Advantages and Disadvantages of Conflict at Work
por: Review, MIT
Publicado: (2018)

Effectiveness studies: advantages and disadvantages
por: Möller, Hans-Jürgen
Publicado: (2011)

Nurses’ Creativity: Advantage or Disadvantage
por: Shahsavari Isfahani, Sara, et al.
Publicado: (2015)

Transoral Thyroidectomy: Advantages and Disadvantages
por: Kim, Wan Wook
Publicado: (2020)

Perineal colostomy: advantages and disadvantages
por: Mulita, Francesk, et al.
Publicado: (2021)

Advantages and Disadvantages of Electronic Cigarettes
por: Sobczak, Andrzej, et al.
Publicado: (2023)

Inclisiran—Silencing the Cholesterol, Speaking up the Prognosis
por: Rogula, Sylwester, et al.
Publicado: (2021)

Inclisiran: a novel drug for the treatment of dyslipidemia
por: Nadeem, Abdullah, et al.
Publicado: (2023)

Neural responses to advantageous and disadvantageous inequity
por: Fliessbach, Klaus, et al.
Publicado: (2012)

Ethyl Chloride—Its Advantages and Disadvantages
Publicado: (1906)

Spinal Anæsthesia, Its Advantages and Disadvantages
por: Struthers, J. W.
Publicado: (1906)

The Advantages and Disadvantages of Human and Animal Lymph
Publicado: (1886)

Integrated Medical Curriculum: Advantages and Disadvantages
por: Quintero, Gustavo A., et al.
Publicado: (2016)

Advantages and Disadvantages of Aluminum as Applied to Dentistry
por: Starr, George O.
Publicado: (1868)

The Advantages and Disadvantages of Esmarch’s Bloodless Method
Publicado: (1875)

Inhibition of connective tissue growth factor by small interfering ribonucleic acid prevents increase in extracellular matrix molecules in a rodent model of diabetic retinopathy
por: Winkler, Jennifer L., et al.
Publicado: (2012)

High-throughput screening of small interfering ribonucleic acid identifies important modulators in islet dysfunction and apoptosis
por: Nemoto, Masami, et al.
Publicado: (2015)

Inclisiran: A New Promising Agent in the Management of Hypercholesterolemia
por: Kosmas, Constantine E., et al.
Publicado: (2018)

Inclisiran: How Widely and When Should We Use It?
por: Pirillo, Angela, et al.
Publicado: (2022)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors
por: Pećin, Ivan, et al.
Publicado: (2017)

The N‐Acetylgalactosamine‐conjugated small interfering RNA inclisiran can be coadministered safely with atorvastatin in cynomolgus monkeys resulting in additive low‐density lipoprotein cholesterol reductions
por: Lehoux, Dario, et al.
Publicado: (2023)

Advantages and Disadvantages of Supersymmetry Breaking at Low Energies
por: Pomarol, Alex
Publicado: (1996)

Overlapping and distinct representations of advantageous and disadvantageous inequality
por: Yu, Rongjun, et al.
Publicado: (2013)

Nanomaterials in the application of tumor vaccines: advantages and disadvantages
por: Li, XD, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1lob331gi85m8c4d8hafomhlkp